Annual EBIT
-$114.61 M
-$76.35 M-199.55%
December 31, 2023
Summary
- As of February 8, 2025, BIOR annual earnings before interest & taxes is -$114.61 million, with the most recent change of -$76.35 million (-199.55%) on December 31, 2023.
- During the last 3 years, BIOR annual EBIT has fallen by -$6.99 million (-6.50%).
- BIOR annual EBIT is now -199.55% below its all-time high of -$38.26 million, reached on December 31, 2022.
Performance
BIOR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$20.25 M
-$27.36 M-384.79%
September 30, 2024
Summary
- As of February 8, 2025, BIOR quarterly earnings before interest & taxes is -$20.25 million, with the most recent change of -$27.36 million (-384.79%) on September 30, 2024.
- Over the past year, BIOR quarterly EBIT has stayed the same.
- BIOR quarterly EBIT is now -384.79% below its all-time high of $7.11 million, reached on June 30, 2024.
Performance
BIOR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$28.41 M
+$50.62 M+64.05%
September 30, 2024
Summary
- As of February 8, 2025, BIOR TTM earnings before interest & taxes is -$28.41 million, with the most recent change of +$50.62 million (+64.05%) on September 30, 2024.
- Over the past year, BIOR TTM EBIT has stayed the same.
- BIOR TTM EBIT is now -30.61% below its all-time high of -$21.75 million, reached on March 1, 2019.
Performance
BIOR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BIOR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -199.6% | 0.0% | 0.0% |
| 3 y3 years | -6.5% | -72.6% | +82.7% |
| 5 y5 years | +0.1% | +58.7% | +79.7% |
BIOR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -199.6% | +31.0% | -384.8% | +74.9% | at high | +84.5% |
| 5 y | 5-year | -199.6% | +31.0% | -384.8% | +74.9% | at high | +84.5% |
| alltime | all time | -199.6% | +31.0% | -384.8% | +74.9% | -30.6% | +84.5% |
Biora Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.25 M(-384.8%) | -$28.41 M(-64.1%) |
| Jun 2024 | - | $7.11 M(-613.7%) | -$79.02 M(-21.9%) |
| Mar 2024 | - | -$1.38 M(-90.0%) | -$101.23 M(-11.7%) |
| Dec 2023 | -$114.61 M(+199.6%) | -$13.89 M(-80.4%) | -$114.61 M(+3.0%) |
| Sep 2023 | - | -$70.86 M(+369.3%) | -$111.25 M(+112.6%) |
| Jun 2023 | - | -$15.10 M(+2.3%) | -$52.33 M(+26.7%) |
| Mar 2023 | - | -$14.76 M(+40.2%) | -$41.29 M(+7.9%) |
| Dec 2022 | -$38.26 M(-77.0%) | -$10.53 M(-11.9%) | -$38.26 M(-64.7%) |
| Sep 2022 | - | -$11.94 M(+194.0%) | -$108.45 M(-16.5%) |
| Jun 2022 | - | -$4.06 M(-65.4%) | -$129.93 M(-20.7%) |
| Mar 2022 | - | -$11.73 M(-85.5%) | -$163.76 M(-10.8%) |
| Dec 2021 | -$166.00 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$80.72 M(+141.6%) | -$183.50 M(+42.7%) |
| Sep 2021 | - | -$33.42 M(-11.8%) | -$128.60 M(+2.2%) |
| Jun 2021 | - | -$37.90 M(+20.4%) | -$125.85 M(+10.0%) |
| Mar 2021 | - | -$31.46 M(+21.9%) | -$114.43 M(-15.5%) |
| Dec 2020 | -$107.62 M(-23.2%) | -$25.82 M(-15.8%) | -$135.50 M(-14.6%) |
| Sep 2020 | - | -$30.67 M(+15.8%) | -$158.65 M(-13.2%) |
| Jun 2020 | - | -$26.48 M(-49.6%) | -$182.82 M(+7.2%) |
| Mar 2020 | - | -$52.53 M(+7.3%) | -$170.47 M(+22.0%) |
| Dec 2019 | -$140.12 M(+22.1%) | -$48.97 M(-10.7%) | -$139.69 M(+54.0%) |
| Sep 2019 | - | -$54.84 M(+288.2%) | -$90.72 M(+152.9%) |
| Jun 2019 | - | -$14.13 M(-35.0%) | -$35.88 M(+65.0%) |
| Mar 2019 | - | -$21.75 M | -$21.75 M |
| Dec 2018 | -$114.77 M | - | - |
FAQ
- What is Biora Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Biora Therapeutics?
- What is Biora Therapeutics annual EBIT year-on-year change?
- What is Biora Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Biora Therapeutics?
- What is Biora Therapeutics quarterly EBIT year-on-year change?
- What is Biora Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Biora Therapeutics?
- What is Biora Therapeutics TTM EBIT year-on-year change?
What is Biora Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BIOR is -$114.61 M
What is the all time high annual EBIT for Biora Therapeutics?
Biora Therapeutics all-time high annual earnings before interest & taxes is -$38.26 M
What is Biora Therapeutics annual EBIT year-on-year change?
Over the past year, BIOR annual earnings before interest & taxes has changed by -$76.35 M (-199.55%)
What is Biora Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BIOR is -$20.25 M
What is the all time high quarterly EBIT for Biora Therapeutics?
Biora Therapeutics all-time high quarterly earnings before interest & taxes is $7.11 M
What is Biora Therapeutics quarterly EBIT year-on-year change?
Over the past year, BIOR quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Biora Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BIOR is -$28.41 M
What is the all time high TTM EBIT for Biora Therapeutics?
Biora Therapeutics all-time high TTM earnings before interest & taxes is -$21.75 M
What is Biora Therapeutics TTM EBIT year-on-year change?
Over the past year, BIOR TTM earnings before interest & taxes has changed by $0.00 (0.00%)